DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,164,500 | -14.9% | 45,000 | -13.6% | 0.32% | +0.3% |
| Q1 2023 | $13,125,487 | +12.9% | 52,077 | +15.7% | 0.32% | -26.7% |
| Q3 2022 | $11,623,000 | -37.6% | 45,000 | -29.1% | 0.43% | -6.5% |
| Q1 2022 | $18,627,000 | -35.3% | 63,500 | -27.4% | 0.46% | -25.5% |
| Q4 2021 | $28,789,000 | -22.1% | 87,502 | -27.9% | 0.62% | -1.0% |
| Q3 2021 | $36,939,000 | +46.5% | 121,335 | +29.2% | 0.62% | +90.5% |
| Q2 2021 | $25,208,000 | -16.4% | 93,935 | -29.9% | 0.33% | -13.7% |
| Q1 2021 | $30,169,000 | +11.6% | 134,037 | +10.1% | 0.38% | -12.4% |
| Q4 2020 | $27,033,000 | -28.8% | 121,694 | -31.0% | 0.43% | -41.0% |
| Q3 2020 | $37,961,000 | -17.9% | 176,294 | -32.6% | 0.74% | -43.7% |
| Q2 2020 | $46,227,000 | +68.3% | 261,420 | +31.8% | 1.31% | -44.4% |
| Q1 2020 | $27,463,000 | -60.1% | 198,420 | -58.3% | 2.35% | +5.1% |
| Q3 2019 | $68,761,000 | -16.5% | 476,087 | -17.4% | 2.24% | -4.7% |
| Q2 2019 | $82,334,000 | +55.9% | 576,087 | +44.0% | 2.35% | +51.8% |
| Q1 2019 | $52,828,000 | +412.3% | 400,149 | +300.1% | 1.55% | +130.4% |
| Q4 2018 | $10,312,000 | -67.0% | 100,000 | -68.4% | 0.67% | +131.7% |
| Q2 2018 | $31,242,000 | +67.2% | 316,600 | +71.1% | 0.29% | +16.5% |
| Q2 2016 | $18,685,000 | +49.0% | 185,000 | +37.0% | 0.25% | -31.4% |
| Q4 2015 | $12,539,000 | +17.7% | 135,000 | +8.0% | 0.36% | +22.2% |
| Q3 2015 | $10,651,000 | -80.6% | 125,000 | -80.5% | 0.30% | -68.5% |
| Q2 2015 | $54,778,000 | -28.6% | 640,000 | -29.2% | 0.94% | -38.3% |
| Q1 2015 | $76,750,000 | +38.1% | 904,000 | +39.5% | 1.53% | +5.4% |
| Q4 2014 | $55,557,000 | +72.1% | 648,202 | +52.6% | 1.45% | +120.5% |
| Q3 2014 | $32,276,000 | +73.0% | 424,800 | +70.7% | 0.66% | +30.3% |
| Q1 2014 | $18,659,000 | +79.0% | 248,789 | +84.3% | 0.50% | +108.7% |
| Q4 2013 | $10,422,000 | +82.9% | 135,000 | +50.0% | 0.24% | +53.2% |
| Q2 2013 | $5,697,000 | – | 90,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |